Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunoablative Protocol for Allogeneic Related and Unrelated Hematopoietic Peripheral Blood Stem Cell Transplant (HPBSC)

NCT00179764 is registered in ClinicalTrials.gov with Ann & Robert H Lurie Children's Hospital of Chicago as lead sponsor.

NCT NCT00179764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00179764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunoablative Protocol for Allogeneic Related and Unrelated Hematopoietic Peripheral Blood Stem Cell Transplant (HPBSC)
Lead sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Phase
Not applicable
Overall status
Completed
Start date
March 10, 2000
Completion date
January 24, 2014
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematological malignancies, leukemia, lymphoblastic, acute, malignant melanoma, myelogenous leukemia, chronic, tumors